Suicide in Two Patients with a Diagnosis of Probable Alzheimer Disease
- 1 April 1999
- journal article
- case report
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 13 (2) , 88-90
- https://doi.org/10.1097/00002093-199904000-00005
Abstract
Two patients meeting the criteria for probable Alzheimer disease (AD) who were participating in a phase 3 clinical program with eptastigmine, a cholinesterase inhibitor, committed suicide. The first patient committed suicide by a self-inflicted gunshot wound to the head. The second patient committed suicide by jumping from a 19th story window. These two patients shared several clinical features with those found in the literature: being at the early stages of the disease, having a high level education, with preserved insight, having access to firearms, and being aware of not responding to pharmacological treatment.Keywords
This publication has 0 references indexed in Scilit: